Skip to main content
. 2021 Oct 19;7:299. doi: 10.1038/s41420-021-00689-5

Fig. 8. A graphical diagram illustrates how TM7SF2 promotes the tumorigenesis of cervical cancer.

Fig. 8

TM7SF2 involves in promotion of cell proliferation, migration, invasion, tumor growth as well as inhibition of cell apoptosis and cell cycle progression. TM7SF2 triggers cervical tumorigenesis via the activation of the C-Raf-ERK pathway, and then promotes cell growth and inhibits apoptosis in cervical cancer.